Bitcoin mining giant Marathon Digital reveals shocking earnings
Miami-based Marathon Digital Holdings (NASDAQ: MARA) announced its second quarter report with a year-over-year revenue rise of 64% to $238 million, while net income jumped 505% to $808.2 million.
Its Bitcoin holdings increased by 49,951 BTC to 18,488 BTC in second quarter of 2024, a year-over-year uptick of 170%. The company attributed the increase to improved mining efficiency and expanded infrastructure.
MARA reported its results in a shareholder letter and will hold a webcast today at 5:00 p.m. ET.
In the days leading up to the announcement, options market sentiment was bullish with five calls versus two puts. Implied volatility indicated that traders were pricing in a move of about 6.8%, or $1.13 per share—right in line with MARA's history of post-earnings moves, with the stock swinging on average by 9.1% over the past eight quarters, as per reports.Although analyst expectations were set at $137.6 million in revenue and $0.11 in EPS, the earnings exceeded expectations, suggesting that operational momentum may be strengthening at Marathon. However, Marathon entered this quarter's earnings season with mixed fundamentals.
While revenue declined by 6.4% over the last twelve months, margin pressures popped up. Marathon had an operating margin of -79.37% and a net margin of -46.68%.
While the company's debt level is manageable, a current ratio of 0.79 means it may not have enough short-term assets to cover its short-term liabilities, raising concerns about near-term liquidity.
Nevertheless, MARA's $5.86 billion market capitalization, with its focus on next-generation mining tech, such as immersion cooling and custom firmware, provides a strong position in the digital asset infrastructure space.
At press time, MARA's price was up over 4.76%, trading at $16.61 in the after hours.
Bitcoin mining giant Marathon Digital reveals shocking earnings first appeared on TheStreet on Jul 29, 2025
This story was originally reported by TheStreet on Jul 29, 2025, where it first appeared.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Amgen Stock Sinks As Market Eyes MariTide's Next Move
Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after markets closed on Tuesday. The US drug maker reported adjusted earnings of $6.02 per share, up 21% year over year, beating the consensus of $5.24. Amgen reported quarterly sales of $9.18 billion, up 9%, beating the Wall Street estimate of $8.87 sales grew 9%, driven by 13% volume growth, partially offset by 3% lower net selling price. Fifteen products delivered at least double-digit sales growth in the second quarter. Outlook Following the strong quarterly performance, Amgen raised fiscal year 2025 adjusted earnings guidance from $20.00-$21.20 per share to $20.20-$21.30 versus the consensus of $20.89. The company raised sales outlook from $34.30 billion-$35.70 billion to $35 billion-$36 billion versus the consensus of $35.29 billion. MariTide in Focus Despite the positive financial results, investor focus remains squarely on the company's experimental weight-loss drug, MariTide. A William Blair analyst noted that investors are 'hyper-focused' on the drug's progress. Part 2 of the Phase 2 chronic weight management study is ongoing in obese patients, with or without type 2 diabetes. Data readout is anticipated in the fourth quarter of 2025. View more earnings on AMGN A Phase 2 study investigating MariTide for type 2 diabetes is ongoing in adults with and without obesity. Data readout is anticipated in the fourth quarter of 2025. Analyst Matt Phipps of William Blair said, 'Given the trial is solely focused on the maintenance setting, we do not believe it will address the key question of tolerability that investors continue to debate.' Analyst Phipps says Amgen shares are up 15% year-to-date, although it remains volatile as investors debate clinical updates with MariTide given the significant market opportunity and competitive landscape. 'We believe Amgen has had meaningful clinical and commercial success with assets including Repatha, Evenity, Blincyto, Tezspire, Imdelltra, and Uplizna that support continued upside on top of the potentially differentiated profile of MariTide, and therefore reiterate our Outperform rating.' Amgen has some near-term headwinds from legacy products, including the recent launch of a biosimilar to Prolia and Xgeva at the end of May 2025 (recent settlement with Sandoz), and the difficulties in gaining more market share with the biosimilar franchises, but the analyst believes clinical catalysts over the next 6 to 12 months will provide meaningful reasons for investor excitement about the long-term growth prospects of the company. Check out . Price Action: AMGN stock is trading lower by 5.10% to $284.97 at last check Wednesday. Read Next:Photo by JHVEPhoto via Shutterstock Latest Ratings for AMGN Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Wells Fargo Maintains Equal-Weight Feb 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for AMGN View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? AMGEN (AMGN): Free Stock Analysis Report This article Amgen Stock Sinks As Market Eyes MariTide's Next Move originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Los Angeles Times
18 minutes ago
- Los Angeles Times
Apple to commit another $100 billion for U.S. manufacturing, White House says
Apple, which was singled out by the Trump administration earlier this year over its production practices, plans to take a further step to highlight its commitment to boosting investment in the U.S. The tech giant will pledge to spend an additional $100 billion on domestic manufacturing, a move that could ease tensions between the tech giant and President Trump who wants iPhones built in the United States. A White House official on Wednesday said Trump will announce a new manufacturing program aimed to bring more of Apple's supply chain to the United States, confirming an earlier report from Bloomberg. Apple's commitment will increase the Cupertino-based company's U.S. investment to $600 billion over four years as it seeks to avoid the cost of tariffs. The company announced a $500-billion U.S. investment commitment in February. Nonetheless, Trump in May criticized Apple for expanding iPhone production in India, threatening to hit the company with a 25% tariff. Apple and other tech companies have touted their U.S. commitments, but analysts and economists have said shifting manufacturing to the United States could take years and result in higher prices for smartphones and other popular electronics. Some analysts have said it would take at least five years for Apple to shift production to the U.S. and the prices of iPhones could reach $3,500 if the smartphone was made in America. The iPhone 16 Pro is made up of roughly 2,700 parts sourced from 187 suppliers in 28 countries, according to an April report from TechInsights. As companies look to keep costs down and consumers watch their budgets, tariffs add another wrinkle to efforts to slash spending. Taylor Rogers, a White House spokesperson, said in a statement, that the Trump and Apple's announcement is 'another win for our manufacturing industry that will simultaneously help reshore the production of critical components to protect America's economic and national security.' This week, Trump said he was doubling tariffs on India to 50%, stating in an executive order that the country's government 'is currently directly or indirectly importing Russian Federation oil.' Apple didn't respond to a request for comment. The move marks the latest apparent effort by Apple to show its commitment to hiring U.S. workers. Last month, the smartphone leader announced the opening of its Apple Manufacturing Academy in Detroit. The program begins Aug. 19 and offers free workshops on artificial intelligence and advanced manufacturing to small and medium-sized businesses. Apple has more than 450,000 jobs with thousands of suppliers and partners across all 50 states. While Apple designs its products in California, it also relies on a global supply chain involving various countries including China, Vietnam and India. Apple is already spending more because of Trump's tariffs. Last week, Apple Chief Executive Tim Cook said during an earnings call that the company has incurred roughly $800 million in tariff-related costs. Apple expects $1.1 billion in tariff-related costs in the fiscal fourth quarter ending in September.
Business Wire
18 minutes ago
- Business Wire
Northern Trust Leaders to Participate in Barclays Global Financial Services Conference on September 9 th
CHICAGO--(BUSINESS WIRE)--Northern Trust Corporation announced today that Chief Financial Officer David Fox and Chief Operating Officer Peter Cherecwich will participate in the Barclays Global Financial Services Conference in New York City on Tuesday, September 9, 2025, at 4:15 p.m. (ET). A live webcast of the event may be accessed via Northern Trust's website ( in the investor relations section. A replay will be available for approximately four weeks after the session date. About Northern Trust Northern Trust Corporation (Nasdaq: NTRS) is a leading provider of wealth management, asset servicing, asset management and banking to corporations, institutions, affluent families and individuals. Founded in Chicago in 1889, Northern Trust has a global presence with offices in 24 U.S. states and Washington, D.C., and across 22 locations in Canada, Europe, the Middle East and the Asia-Pacific region. As of June 30, 2025, Northern Trust had assets under custody/administration of US$18.1 trillion, and assets under management of US$1.7 trillion. For more than 135 years, Northern Trust has earned distinction as an industry leader for exceptional service, financial expertise, integrity and innovation. Visit us on Follow us on Instagram @northerntrustcompany or Northern Trust on LinkedIn. Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S. Global legal and regulatory information can be found at
